相关实验视频

Updated: Jan 8, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

皮佩拉和环素电离性脂质的合理设计和应用,用于PKU和SSADH缺乏症

Jiyeon Son^1,2, Hyunjung Yoo¹, Joonyoung Park¹

¹Department of Research & Development, GC Biopharma Corp., Yongin-si, Gyeonggi-do 16924, Republic of Korea.

Molecular therapy. Nucleic acids

|December 15, 2025

概括

新的脂质纳米颗粒 (LNP) 对mRNA疗法具有前景. 基于环素的LNP提供稳定的表达和减少重复剂量的毒性,改善治疗潜力.

科学领域:

生物技术是生物技术.
药物运输药物运输药物运输
分子生物学分子生物学

背景情况:

使用脂质纳米粒子 (LNP) 进行mRNA疗法的重复剂量面临着效率降低和毒性增加的挑战.
目前的LNP配方,通常是为疫苗设计的,对于需要长期使用的治疗应用来说没有优化.

研究的目的:

为基于mRNA的蛋白质替代疗法开发新的电离性脂质配方.
评估在重复剂量条件下基于皮佩拉津和环素的新型LNP (GCP LNP) 的疗效和安全性.

主要方法:

合成了两种电离性脂质库,包括piperazine和新型环素结构,具有多样化的左边和尾部组.
评估了LNP表达蛋白,肝毒性和治疗标志物校正的表现,在小鼠模型中评估了基尿症 (PKU) 和半脱酶 (SSADH) 缺乏.

主要成果:

在重复剂量中,GCP LNPs表现出稳定,高水平的蛋白质表达,而不会诱导肝脏毒性.
基于环素的LNP表现出持续的输送性能,这是由于它们的刚性结构和化学稳定性.
在使用这些新型LNP的PKU和SSADH缺陷小鼠模型中观察到疾病标志物的有效校正.

结论:

基于循环和皮佩拉的新型LNP为基于mRNA的蛋白质替代疗法提供了一个有前途的平台.
基于环素的脂质的独特特性增强了持续的输送,解决了当前LNP配方的局限性.
这些发现为开发更安全,更有效的慢性mRNA疗法铺平了道路.

关键词:

MT:交付策略的交付策略这是一个PKU PKU.对于RNA疗法来说,它是非常重要的.在SSADH,它是SSADH.可离子化脂质的离子化脂质脂质纳米颗粒是一种纳米粒子.

更多相关视频

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

相关概念视频

Pore Transport and Ion-Pair Transport

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...